Picture EBD Group World of Partnering Opportunities 650x100px

Document › Details

Roche. (5/17/18). "Press Release: Phase III IMpower150 Study Showed Roche’s Tecentriq and Avastin plus Carboplatin and Paclitaxel Helped People with a Specific Type of Metastatic Lung Cancer Live Significantly Longer Compared to Avastin plus Carboplatin

	Organisation	Roche (Group)
	Product	Tecentriq®
	Product 2	clinical research
	Person	Horning, Sandra (Roche 201401–201912 CMO + Head Global Product Development joined 2009 RETIRED 12/19)

Original document
accessed by [iito] on 2018-05-22

Record changed: 2023-06-05

Picture EBD Group Biotech Showcase 2024 San Francisco 650x200px

More documents for Roche (Group)

[1] Genentech, Inc.. (11/21/23). "Press Release: Genentech and Nvidia Enter Into Strategic AI Research Collaboration to Accelerate Drug Discovery and Development". South San Francisco, CA....
[2] Roche. (10/23/23). "Press Release: Roche Enters into a Definitive Agreement to Acquire Telavant". Basel....
[3] SpliceBio S.L.. (10/17/23). "Press Release: SpliceBio Enters Collaboration with Spark Therapeutics to Develop a Gene Therapy Targeting an Inherited Retinal Disease". Barcelona....
[4] CombiGene AB. (10/14/23). "Press Release: Spark Therapeutics Terminates Collaboration Agreement for the Epilepsy Project CG01 with CombiGene". Stockholm....
[5] Roche. (7/24/23). "Press Release: Roche Enters Partnership with Alnylam to Co-develop and Co-commercialise RNAi Therapeutic Zilebesiran to Treat Hypertension in Patients with High Cardiovascular Risk". Basel....
[6] Zion Pharma Ltd.. (5/9/23). "Press Release: Zion Pharma Announces Global Agreement with Roche to Develop and Commercialize a Blood Brain Barrier Penetrant Oral HER2 Tyrosine Kinase Inhibitor". Hong Kong, Suzhou & Shanghai....
[7] Roche. (3/22/23). "Press Release: Roche Announces Collaboration with Lilly to Enhance Early Diagnosis of Alzheimer's Disease". Basel....
[8] Hookipa Pharma Inc.. (2/13/23). "Press Release: Hookipa Achieves $10 Million Milestone Payment in Development of Immunotherapy for KRAS-Mutated Cancers". New York, NY & Vienna....
[9] Bayer AG. (2/8/23). "Press Release: Bill Anderson to Become CEO of Bayer AG". Leverkusen....
[10] Epigenomics AG. (1/27/23). "Press Release: Resignation of Supervisory Board Chairman Heino von Prondzynski". Berlin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]